AWM/NAW/12/2025/TM

1. Subject of order:

1. Type of order: Social services

Name and code in line with CPV:

80000000-4 – Educational and training services

2. Description of order subject:

1. The order concerns the project entitled “Intensification of internationalization process and development of the Doctoral School of the Medical University of Bialystok” financed by the Polish National Agency for Academic Exchange as part of the programme of the Agency called “STER NAWA – Internationalization of Doctoral Schools – call 2024”.
2. The subject of the order is preparation and conduct of the training service in 2026, consisting in the realization of classes in English in the selected form (lectures, practical classes, seminars, individual consultations etc.) in the stationary mode for doctoral students of the Doctoral School of the Medical University of Bialystok.
3. The training service will be realized in the division into the following parts (the offer may be submitted for one or several parts of the order in question):

Part I

Class title:

Pathophysiology of sleep apnea syndrome

Thematic scope of the training:

• Presentation of what sleep apnea syndrome is and how it affects the body.
• Discussion of the disease mechanisms and the effects of hypoxia and sleep disturbances.
• Presentation of the challenges in diagnosing and classifying sleep apnea.
• Discussion of available treatment methods, including their limitations and therapeutic dilemmas.

Part II

Topic of classes:

Dilemmas in the treatment of sleep apnea syndrome

Thematic scope of the training:

• The Sleep Apnea Conundrum: Understanding the Disease Spectrum.
• Advanced Diagnostics: Finding the Root Cause of Obstruction.
• The Central Paradox: When CPAP Isn't Enough - The decision to pursue non-PAP therapies.
• Retropalatal Surgery: The Trade-Off Between Efficacy and Safety - The shift from ablative to reconstructive surgery.
• Neuromodulation vs. Craniofacial Advancement: High-Tech Solutions.
• The Management of Recurrence: Designing a Rescue Protocol and systematically address a complex failure.

PART III

Class title:

Integrative biomedicine

Thematic scope of the training:

• History, current situation and future perspective of the 21st century integrative biomedicine.
• Selected methods of integrative biomedicine.
• European and global aspects of integrative biomedicine linked through R&D and education projects.
• Innovative aspects of integrative biomedicine, entrepreneurial and research options.
• Own ideas and experience of the lecturer and participants.

PART IV

Class title:

Oxidative stress in oncology

Thematic scope of the training:

• Basic aspects of cancer development and tumour: host relationships.
• Free radicals, oxidative stress and lipid peroxidation – physiology, pathophysiology and pathology.
• Analytical tolls, methodology and challenges in oxidative stress monitoring.
• Specific aspects of oxidative stress in oncology, therapeutic options included.
• Spontaneous regression of cancer.

PART V

Class title:

Myofunctional Therapy, Effectiveness of Treating Sleep Apnea Syndrome

Thematic scope of the training:

• Definition and history of myofunctional therapy (MT), Anatomy and physiology of the upper airway and oropharyngeal muscles, Pathophysiology of obstructive sleep apnea (OSA).
• Current therapeutic approaches for OSA: CPAP, surgical options, mandibular advancement devices, rationale for MT in OSA: evidence from clinical practice and emerging research.
• Review of clinical evidence supporting MT in OSA (randomized trials, systematic reviews, meta-analyses), digital health and telemedicine: app-based delivery of MT (example: Airway Gym®).
• Integration of MT with other OSA treatments (e.g., MAD, CPAP, surgery).
• Monitoring progress: clinical tools (IOPI, manometry, 3D imaging, polysomnography).
• Barriers to implementation and strategies to improve adherence.
• Future research directions and unmet needs in MT and OSA.

PART VI

Class title:

Rickettsiosis in Europe: Clinical symptoms

Thematic scope of the training:

• Historical background: discovery of rickettsial diseases (Howard Ricketts, Rocha-Lima, etc.), role in major epidemics (e.g., louse-borne typhus in wars and famines), evolution of knowledge up to present times.
• General overview of rickettsioses: group of zoonotic diseases caused by Rickettsia spp., transmission via arthropods (ticks, fleas, lice; mention of unusual reports such as leeches in Chile).
• Occurrence of arthropods that transmit zoonotic diseases, specific associations between Rickettsia species, vectors, and clinical syndromes.
• Rickettsioses in Europe: most frequent cases and geographic distribution, potential for outbreaks in wars, natural disasters, or overpopulation.
• Pathogenesis: vascular involvement (vasculitis), organ and systemic infections, multi-organ failure and the role of the immune response.
• Clinical spectrum: mediterranean spotted fever (MSF), African tick-bite fever (imported), other tick-borne rickettsioses (e.g., DEBONEL/TIBOLA), flea- and louse-borne rickettsioses.
• Importance of epidemiological history, recognition of clinical symptoms.

PART VII

Class title:

Microbiological diagnosis in rickettsiosis

Thematic scope of the training:

• Diagnosis of rickettsiosis in clinical conditions, treatment in case of suspected rickettsiosis.
• Culturing of Rickettsia spp using cell lines in a facility with biosafety level 3.
• Direct diagnosis of rickettsiosis using nucleic acid detection (PCR) and tissue staining.
• Indirect diagnosis by antibody detection.
• Diagnosis by using different types of samples depending on the availability of a given technique and the stage of the disease.
• Occurrence of different types of target genes in PCR diagnosis.
• Usefulness of next-generation sequencing under integrative taxonomy approaches.
• Limitations in serological diagnosis.
• The value of clinical and laboratory guidelines.

PART VIII

Class title:

The thiazolidinone motif in drug discovery

Thematic scope of the training:

• Current trends in medicinal chemistry and pharmacology of thiazolidinediones and their derivatives.
• Peculiarities of the "structure - biological activity" relationship in the series of thiazolidinones and related heterocyclic systems.
• Peculiarities of molecular design of new thiazolidinone-based biologically active compounds.
• Ability to carry out critical assessment of scientific information taking into consideration the methodological correctness and interpretation of the obtained scientific research results medicinal chemistry.
• Advances in medicinal chemistry and molecular biology of thiazolidinone derivatives. Experience in implementing projects in a partnership formula.
• Development of international scientific partnerships in the field of drug design.

PART IX

Class title:

Epidemiology, population studies, genetic studies and prevention

Thematic scope of the training:

• Introduction to thyroid epidemiology.
• Prevention of iodine deficiency-related disorders.
• Use and misuse of reference values.
• Population imaging.
• Standardization and quality assurance.
• Is there a non-alcoholic liver disease?

PART X

Class title:

Molecular basis of oncogenesis

Thematic scope of the training:

• Overview of different types of cancer and mechanisms of oncogenesis.
• General and targeted cancer therapies.
• Mechanisms of mutagenesis and chromosomal aberrations.
• Epigenetics of cancer.
• Oncogenes and drugs targeting oncogenes.
• Viruses, infections, and cancer.

PART XI

Class title:

Maximal fatty acid oxidation rate as a determinant of physical performance

Thematic scope of the training:

• Measuring fat oxidation and maximal fat oxidation (MFO/PFO) in man.
• Substrate utilization during exercise, endogenous and exogenous contributions.
• Is MFO/PFO linked to exercise/sports performance?
• Bioactive lipids and insulin resistance.
• What are factors limiting fat oxidation in muscle during exercise.
• Metabolic inflexibility – definitions and issues?
• Practical determination of MFO/PFO and VO2max (concepts, limitations, problems).

PART XII

Class title:

Fundamentals of diagnostic clinical neurochemistry

Thematic scope of the training:

• The role of cerebrospinal fluid in contemporary neuropsychiatric diagnostic with particular emphasis on neurodegenerative diseases.
• Anatomy and psychology of cerebrospinal fluid.
• Protein diffusion through the blood-cerebrospinal fluid barrier. Hyperbolic function of H. Reiber.
• Introduction to clinical neuroimmunology and the role of cerebrospinal fluid in the diagnosis of neuroinflammatory diseases (MS, GBS, neuroborreliosis).
• Pathophysiology of Alzheimer's disease, amyloid hypothesis and the role Tau protein.
• The diagnostic role of cerebrospinal fluid in neurodegenerative diseases with a focus on Alzheimer’s disease.
• Interpretation of the result: Erlangen Score.
• Limitations in the study of cerebrospinal fluid: important pre-analytical aspects.
• The role of blood-derived biomarkers: can we abandon lumbar puncture and study cerebrospinal fluid now?
• Introduction to the basics of biostatistics in laboratory studies. 

PART XIII

Class title:

Fragmentation mechanisms

Thematic scope of the training:

• Introduction to fragmentation mechanisms and their role in chemical analyses.
• Overview of the main types of fragmentation processes.
• Discussion of general principles and factors influencing the course of fragmentation.
• Basic techniques used to study fragmentation.
• Application of fragmentation knowledge in structural analysis and diagnostics.

PART XIV

Class title:

Fundamentals of drug discovery and development 

Thematic scope of the training:

• The journey of a new therapy: Discovery and development.
• Preclinical research: Purpose of preclinical studies in oncology; Cell-based assays; In vivo models for cancer screening; Emerging non-animal models; High-throughput screening.
• Clinical research: Definition of clinical research and historical milestones; Types of Clinical Research; Clinical Trial Phases; Clinical research in rare diseases.
• Regulatory Pathways: Role of FDA, EMA, and other agencies; IND (Investigational New Drug) and NDA (New Drug Application) processes; Ethical considerations (informed consent, GCP guidelines); FDA review; FDA post-market safety monitoring.
•  Emerging Trends in Drug Discovery: Monoclonal antibodies, peptides; RNA-based therapeutics; Personalized/precision medicine; Immunotherapy and cell-based therapies.
• AI-driven drug discovery: De Novo Drug Design - Virtual screening & molecular docking acceleration with AI; Lead Optimization; AI in Preclinical and Clinical Development.

4. Organizational information regarding the planned classes:

The classes will be held in person at the Ordering Party's headquarters, in a form chosen by the Contractor (lecture, seminar, individual consultations, etc.).

The exact form of the classes will be agreed with the Contractor well in advance before the start of the classes.

The classes within each part (I - XIV) will be held in the calendar year 2026.

Individual classes will be held in one day or divided into two or three days. The time of implementation depends on the topic and its thematic scope.

The exact dates and hours of the classes will be agreed in working mode between the Ordering Party and the Contractor well in advance, at least 30 days before the planned date of conducting the individual classes.

The classes will be held no earlier than 8:00 a.m. local time in Poland and no later than 7:00 p.m. local time in Poland.

Planned number of days and hours of classes:

PART I: 10 didactic hours - 6 days (in the form of a 2 hour-long-lecture, 4 hour-long seminar, 4 hour-long consultations).

PART II: 7 didactic hours - 6 days (in the form of a 3 hour-long lecture, 4 hour-long seminar).

PART III: 4 didactic hours - 1 day (in the form of a 3 hour-long-lecture, 1 hour-long seminar).

PART IV: 7 didactic hours – 2 days (in the form of a lecture).

PART V: 6 didactic hours - 3 days (in the form of a 2 hour-long lecture, 2 hour-long seminar, 2 hour-long consultations).

PART VI: 2 didactic hours – 1 day (in the form of a lecture).

PART VII: 2 didactic hours – 1 day (in the form of a lecture).

PART VIII: 15 didactic hours – 3 days (in the form of a 5 hour-long lecture, 10 hour-long practical classes).

PART IX: 15 didactic hours – 3 days (in the form of a 10 hour-long lecture, 5 hour-long seminar).

PART X: 15 didactic hours – 3 days (in the form of a lecture).

PART XI: 6 didactic hours – 3 days (in the form of a 4 hour-long lecture, 2 hour-long practical classes).

PART XII: 6 didactic hours – 3 days (in the form of a 4 hour-long seminar, 2 hour-long consultations).  

PART XIII: 20 didactic hours – 5 days (in the form of a 10 hour-long lecture, 10 hour-long seminar).

PART XIV: 15 didactic hours – 3 days (in the form of a 12 hour-long seminar, 3 hour-long seminary). 

The Ordering Party allows for the submission of partial offers divided into XIV parts, whereby the term partial offer shall be understood as one or more parts specified in this description of the subject of the order, specified by the Ordering Party.

The Ordering Party will consider each partial offer separately.

Offers for incomplete parts will be rejected as incomplete.

Each part indicated in the description of the subject of the order constitutes a separate part and will be subject to a separate procedure related to the selection of the most advantageous offer.

5. Requirements for Contractors:

PART I

• Having at last a PhD in medical or related fields and employed over the last 10 year (with at least 5 years of employment) as an associate professor or higher at a foreign research centre (university or research institute).
• Having at last 5 years of teaching experience, in particular conducting lectures and practical classes in English in the field of sleep apnea syndrome.
• Having at least 5 publications in international journals over the last 5 year is the field of sleep apnea syndrome.
• Participation in presentations activities in international forms, e.g. conferences, in the last 5 years.

PART II

• Having at least a PhD in medical or related fields and employment over the last 10 years (with at least 5 years of employment) as an associate professor or higher at a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular conducting lectures and practical classes in English in the field of obstructive sleep apnea.
• Having at least 5 publications in international journals over the last 5 years in the field of obstructive sleep apnea.
• Participation in presentation activities in international forums, e.g. conferences, in the last 5 years.

PART III

• Having at least a PhD in medical or related fields and employment in the last 10 years (at least 5 years of employment) as an associate professor or higher in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular: conducting lectures and practical classes in English in the field of integrative biomedicine.
• Having at least 5 publications in international journals in the last 5 years in the field of integrative biomedicine.
• Participation in presentation activities in international bodies, e.g. at conferences, in the last 5 years.

PART IV:

• Having at least a doctoral degree and employment within the last 5 years (at least 2 years of employment) as an associate professor in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular: conducting lectures and practical classes in English in the field of oxidative stress in oncology.
• Having at least 5 publications in international journals within 5 years in the field of oxidative stress in oncology.
• Participation in presentation activities in international bodies, e.g. at conferences, within the last 5 years.

PART V:

• Having at least a doctoral degree in medical or related fields and employment within the last 10 years (at least a 5-year employment period) as an associate professor or higher at a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, including conducting lectures and practical classes in English in the field of myofunctional therapy, pathophysiology, and treatment of obstructive sleep apnea syndrome.
• Having at least 5 publications in international journals within the last 5 years related to myofunctional therapy and treatment of sleep apnea syndrome.
• Active participation within the last 5 years in international scientific forums, symposia, and conferences as a speaker, moderator, or panelist.

PART VI:

• Having at least a PhD in medical or related fields and employment in the last 10 years (at least 5 years of employment) as an associate professor or higher in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular: conducting lectures and practical classes in English in the field of tick-borne diseases.
• Having at least 5 publications in international journals in the last 5 years in the field of tick-borne diseases.
• Participation in presentation activities in international bodies, e.g. at conferences, in the last 5 years.

PART VII:

• Having at least a PhD in medical or related fields and employment in the last 10 years (at least 5 years of employment) as an associate professor or higher in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular: conducting lectures and practical classes in English in the field of tick-borne diseases.
• Having at least 5 publications in international journals in the last 5 years in the field of tick-borne diseases.
• Participation in presentation activities in international bodies, e.g. at conferences, in the last 5 years.

PART VIII:

• Having at least a PhD in medical or related fields and employment in the last 10 years (at least 5 years of employment) as an associate professor or higher in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular: conducting lectures and practical classes in English in the field of medicinal chemistry.
• Having at least 10 publications in renowned international journals within 5 years in the field of medicinal chemistry.
• Participation in presentation activities in international bodies, e.g. at conferences, within the last 5 years.

PART IX:

• Having at least a doctoral degree in medical or related fields and employment within the last 10 years (at least 5 years of consecutive employment period) as an associate professor or higher in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular: conducting lectures and practical classes in English in the field of epidemiology, prevention or genetics.
• Having at least 5 publications in international journals within 5 years in the field of epidemiology, population studies, genetic studies or disease prevention.

PART X:

• Having at least a PhD in medical or related fields and employment in the last 10 years (at least 5 years of employment) as an associate professor or higher in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular: conducting lectures and practical classes in English in the field of molecular basis of oncogenesis.
• Having at least 5 publications in international journals in the last 5 years in medical, biological, or related life science fields.

PART XI:

• Holding at least a doctoral degree in medical sciences or related fields, and employment within the last 10 years (for a period of at least 5 years) in a position of associate professor or higher at a foreign research institution (university or research institute).
• Having at least 5 years of teaching experience, in particular in delivering lectures and practical classes in English in the field of exercise physiology and fatty acid metabolism.
• Having at least 5 publications in international journals within the last 5 years concerning exercise physiology and fatty acid metabolism.
• Participation in presentation activities in international forums within the last 5 years, e.g. at conferences.

PART XII:

• Having at last a doctoral degree in medical sciences or related fields, and employment within the last 10 years (for a period of at least 5 years) in a position of associate professor or higher at a foreign research institution (university or research institute).
• Having at least 5 years of teaching experience, in particular in delivering lectures and practical classes in English in the field of neurodegenerative disease.
• Having at least 5 publications in international journals within the last 5 years concerning neurodegenerative diseases.
• Participation in presentation activities in international forums within the last 5 years, e.g. at conferences.

PART XIII:

• Having at least a PhD degree in chemical, medical or related sciences and employment within at least 10 years (at least 5 years od consecutive employment period) in a foreign research centre (university or research institute).
• Having at least 5 years of teaching experience, in particular in delivering lectures and practical classes in English in the field of fragmentation mechanisms, mass spectrometry.
• Having at least 5 publications in international journals within the last 5 years concerning fragmentation mechanisms, mass spectrometry.  
• Participation in presentations activities in international forums within the last 5 years, e.g. at conferences.  

PART XIV:

• Having at least a PhD degree in medical or biological, or related fields, and employment within the last 10 years (at least 5 years of consecutive employment period) in a foreign research centre (university or research institute).
• Having at least 10 publications in international journals Q1-Q2 within 5 years in the field of pharmacology, drug development, cell and cancer biology.

6. Target group

The target group comprises doctoral students from the Doctoral School at the Medical University of Bialystok.

All participants taking part in classes have a high command of English.

PART I – XIV:

The classes will be conducted in the form of additional classes going beyond the standard study program.    

7. Planned date and place of service provision:

The classes will be conducted in the calendar year 2026, in stationary mode, at the headquarters of the Ordering Party, i.e. the Medical University of Bialystok (ul. Jana Kilińskiego 1, 15-089 Białystok, Poland).

8. Form of classes:

• all classes will be conducted in a closed formula - only with the participation of doctoral students of the Ordering Party's Doctoral School;
• the Contractors must personally complete the subject of the order;
• all classes will take the form selected by the Contractor from the available possible forms (lecture, seminar, individual consultations, etc.);
• the classes will be conducted for one group of doctoral students, consisting of about 10 people (it may be a smaller or larger group);
• the Contractor will conduct classes in a form that activates participants with the possibility of asking questions and discussions;
• the Contractor will enable the participants of the classes to have consultations and provide feedback.

9. Organizational issues related to the implementation of the subject of the order:

• all classes will be conducted in English;
• the Ordering Party will appoint a person responsible for organizational issues related to the implementation of the subject of the order;
• the preparation and collection of the necessary documentation from the classes: originals of attendance lists, class journals and confirmation of receipt of certificates on bilingual templates provided by the Ordering Party, is the responsibility of the Ordering Party;
• the Ordering Party will cover the costs of the Contractor's travel from his place of residence to Białystok and the return trip, the costs of accommodation in Białystok and statutory allowances applicable in Poland;
• the Contractor will sign certificates confirming participation in the classes, containing logos and the name of the project, which will be prepared by a person designated by the Ordering Party, the originals of the certificates will be sent by post;
• the final report will be prepared by a person designated by the Ordering Party in consultation with the Contractor.

The Contractor will inform the participants during the first hour of classes that the classes are carried out as part of the project entitled “Intensification of internationalization process and development of the Doctoral School of the Medical University of Bialystok” which is financed by the Polish National Agency for Academic Exchange as part of the programme called:
 “STER NAWA– Internationalization of Doctoral Schools – call 2024”.

The Ordering Party shall ensure appropriate accessibility of the service, which is the subject of the order, to all participants of the classes, in accordance with applicable standards. The service will be provided in accordance with the principles of equal opportunities and non-discrimination, accessibility for people with disabilities and the principle of gender equality.

The Contractor will be obliged to comply with the equal opportunities policy during the implementation of the classes, in particular the use of equal language.

In the case of classes lasting longer than two teaching hours, the Ordering Party provides for 15-minute breaks, carried out in cycles every two consecutive teaching hours. However, breaks are not included in the total duration of the classes that are the subject of this request for proposals.

The Ordering Party is responsible for organizational issues related to the implementation of the classes (recruitment of participants, issuing certificates, possible organizational assistance, etc.).

3. Criteria of assessment

The offers will be assessed by the Ordering Party separately for all parts of the order based on the following criterion:

Offer price – maximum number – 100 points

Principles for assessing the “Offer price” criterion:

• in the offer form, the Contractor will provide the gross price for the execution of the order in a given part.
• The assessment in this criterion will be made using the following formula:

Number of points = lowest offered price / price of the offer being assessed x 100

• The most advantageous offer will receive 100 points in this criterion.

2. Term or period of order execution

The order will be realized in the calendar year 2026.

The final date of service completion, within the above-mentioned time frame, will be established in the working mode between the Ordering Party and the Contractor after signing the agreement, at least 30 days in advance of the planned start date of the individual classes.

3. Submission of offers

1. Detailed information can be obtained at:

The Medical University of Bialystok, ul. J. Kilińskiego 1, 15-089 Białystok

International Cooperation Department, room no. 213 (Right Wing of Braniccy Palace).

2. Contact person for the Contractors:

Patrycja Jasińska, e-mail: patrycja.jasinska@umb.edu.pl.

3. The following must be attached to the offer form (appendix to the request for proposals):

1) Statement on lack of personal or capital connections with the Ordering Party.

2) Copy of documents confirming the possessed professional experience (i.e. Professional curriculum vitae, list of scientific publications, copies of diplomas and other documents etc.). The documents should contain information necessary to entrust the required professional qualifications, entitlements, experiences and education necessary to complete the order.

4. Term of submission of offers (date and time): 30-12-2025 at 3 p.m. Polish time

      Place: The Medical University of Bialystok

1. The offer should be submitted via e-mail by sending scans of signed documents to the e-mail address: tomasz.maliszewski@umb.edu.pl

• Offers submitted or received after the above-specified term shall not be considered;
• The offers should be submitted in English.

5. The Medical University in Białystok reserves the right to:

• refrain from considering offers submitted after the deadline;
• cancel the proceeding without stating the reasons;
• change the scope of the proceeding.

Appendices:

Appendix No. 1 – sample offer form

Appendix No. 2 – template of Agreement

Appendix No. 3 – sample statement on lack of personal or capital connections with the Ordering Party

Information clause concerning processing of personal data

In accordance with Art. 13 par. 1 and 2 of the Regulation of European Parliament and Council (EU) 2016/679 from 27 April 2016 on protection of natural persons in relation to the processing of personal data and on the free flow of such data and repelling Directive 95/46/EC (general regulation on data protection) (Journal of Laws EU L 119 from 04.05.2016, p. 1) further “GDPR” please be informed that:

1. the controller of personal data is the Medical University of Bialystok, ul. Jana Kilińskiego 1, 15-089 Białystok, NIP 542-021-17-17, REGON 000288604, represented by the Rector;
2. Contact to the personal Data Protection Officer: iod@umb.edu.pl;
3. personal data will be processed on the basis of art. 6 sec. 1 letter b of the GDPR for the purpose of concluding a contract based on the submitted offer and on the basis of art. 6 sec. 1 letter a of the GDPR for the purpose of assessing the submitted offer and contacting the bidder;
4. recipients of personal data may be contractors, persons requesting access to public information, entities authorized under the provisions of law and entities based on entrustment agreements concluded with the Ordering Party;
5. personal data will be stored for the period resulting from the provisions of law, i.e. 5 years from the date of termination of the contract;
6. providing personal data is voluntary, however, failure to provide them may prevent the Ordering Party from assessing the offer, which will result in the rejection of the offer or exclusion from the procedure;
7. decisions regarding personal data will not be made in an automated manner, in accordance with art. 22 of the GDPR;
8. the contractor has: under art. 15 of the GDPR the right to access personal data, under art. 16 of the GDPR the right to rectify personal data 1, under art. 18 of the GDPR the right to request the controller to restrict the processing of personal data, subject to the cases referred to in art. 18 sec. 2 of the GDPR 2, the right to lodge a complaint with the President of the Office for Personal Data Protection, if the Contractor considers that the processing of personal data concerning the Contractor violates the provisions of the GDPR;
9. the Contractor is not entitled to the right to delete personal data in connection with art. 17 sec. 3 letters b, d or e of the GDPR, the right to transfer personal data, referred to in art. 20 of the GDPR, under art. 21 of the GDPR the right to object to the processing of personal data, as the legal basis for the processing of personal data is art. 6 sec. 1 letter c of the GDPR.  

1. Explanation: exercising the right to rectification cannot result in a change in the outcome of the competition or a change in the provisions of the contract

2. Explanation: the right to restrict processing does not apply to storage for the purpose of protecting the rights of another natural or legal person, or for important reasons of public interest of the European Union or a Member State.